AUA Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

AUA Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,500	Closed	-$10K	–	186
2019 Q3	$10K	Hold	1,500	–	–	0.01%	162
2019 Q2	$14K	Hold	1,500	–	–	0.01%	151
2019 Q1	$24K	Hold	1,500	–	–	0.02%	131
2018 Q4	$23K	Hold	1,500	–	–	0.02%	130
2018 Q3	$32K	Hold	1,500	–	–	0.03%	128
2018 Q2	$36K	Hold	1,500	–	–	0.03%	129
2018 Q1	$26K	Hold	1,500	–	–	0.02%	137
2017 Q4	$28K	Hold	1,500	–	–	0.03%	136
2017 Q3	$26K	Hold	1,500	–	–	0.02%	136
2017 Q2	$50K	Hold	1,500	–	–	0.04%	124
2017 Q1	$48K	Hold	1,500	–	–	0.05%	102
2016 Q4	$54K	Buy	+1,500	New	+$59.9K	0.05%	117

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

AUA Capital Management's TEVA Position: Q4 2019 in Review

AUA Capital Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2019, closing a stake of 1,500 shares — an estimated $10K sold.

AUA Capital Management first reported a position in TEVA in Q4 2016 and held it in 12 quarters. The position peaked at $54K in Q4 2016. 437 funds tracked by Wall St. Rank hold TEVA as of Q4 2019.

AUA Capital Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2019 after selling out during the quarter.
AUA Capital Management sold 1,500 Teva Pharmaceutical Industries Limited shares in Q4 2019, an estimated $10K.
AUA Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2016 and held it in 12 quarters.
AUA Capital Management's Teva Pharmaceutical Industries Limited position peaked at $54K in Q4 2016.
437 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2019.

Based on AUA Capital Management's 13F filing for Q4 2019, filed 10 Jan 2020.